Zyrorab D 30mg/20mg Capsule SR
Images are for reference. Actual packaging may vary.
1 units • OtherPrescription requiredSchedule H
Zyrorab D 30mg/20mg Capsule SR
Domperidone (30mg) + Rabeprazole (20mg)
₹85.00
1 units • Other
A valid prescription is required for this medicine.
1
Delivery
Safe & Secure
Easy Returns
24/7 Support
SMARTER CARE
A little guidance.
A better choice.
Haven’t found an alternative? A health advisor can help you understand what to do next.
No matching alternative found
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Rabeprazole 20 mg
+1 more active ingredient
How It Works
Rabeprazole irreversibly inhibits the H+/K+ ATPase enzyme in gastric parietal cells, reducing gastric acid secretion.
Domperidone antagonizes dopamine D2 receptors in the chemoreceptor trigger zone, inhibiting nausea and vomiting.
Medicine Strength
20 mg
All Active Ingredients
Rabeprazole20 mg
Domperidone30 mg
Uses & Benefits
Medical applications
HeadacheFluUlcerNausea
Zyrorab D 30mg/20mg Capsule SR is a combination pharmaceutical formulation containing Domperidone 30mg and Rabeprazole 20mg, designed for the effective management of gastrointestinal disorders. Domperidone, a peripheral dopamine D2 receptor antagonist, facilitates gastric motility and accelerates gastric emptying, thereby alleviating symptoms such as nausea, vomiting, bloating, and discomfort associated with delayed gastric emptying or gastroparesis.
Read full descriptionShow less
Rabeprazole, a proton pump inhibitor (PPI), suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, providing symptomatic relief in acid-related conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. The sustained-release (SR) formulation ensures prolonged therapeutic plasma concentrations, enhancing patient compliance through reduced dosing frequency.
Zyrorab D is indicated for patients requiring combined prokinetic and acid suppression therapy, optimizing symptom control and mucosal healing. It should be administered under medical supervision, with caution advised in patients with cardiac arrhythmias, hepatic impairment, or known hypersensitivity to either component. Common adverse effects may include headache, dry mouth, and gastrointestinal disturbances.
Drug interactions should be carefully evaluated, particularly with medications metabolized via CYP3A4. Zyrorab D 30mg/20mg Capsule SR offers a synergistic approach for comprehensive management of upper gastrointestinal motility and acid-related disorders.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Safety information not available for this product. Please consult your doctor or pharmacist.
Customer Reviews
0 reviews for Zyrorab D 30mg/20mg Capsule SR
